Abstract
The implantation of titanium (Ti) devices results in a transient inflammatory process of low magnitude, compatible with constructive inflammation, leading to osseointegration. The presence of mesenchymal stem cells (MSCs) at the sites of implantation, apart from their immunoregulatory characteristics, and the participation of the CXCL12-CXCR4 axis, suggests their involvement in this proce…